Search Results

TRX818 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

antineoplastic and anti-vasculogenic mimicry (VM) activities

More Information Supplier Page

×

TRX818

mavatrep 100mg  | 98%

APEXBIO TECHNOLOGY LLC

TRPV1 antagonist Membrane Transporter/Ion Channel|TRPV1

More Information Supplier Page

×

mavatrep

mavatrep 50mg  | 98%

APEXBIO TECHNOLOGY LLC

TRPV1 antagonist Membrane Transporter/Ion Channel|TRPV1

More Information Supplier Page

×

mavatrep

mavatrep 10mg  | 98%

APEXBIO TECHNOLOGY LLC

TRPV1 antagonist Membrane Transporter/Ion Channel|TRPV1

More Information Supplier Page

×

mavatrep

Decernotinib(VX-509) 2mg  | 99.21%

APEXBIO TECHNOLOGY LLC

Selective and orally active JAK3 inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Decernotinib(VX-509)

Decernotinib(VX-509) 5mg  | 99.21%

APEXBIO TECHNOLOGY LLC

Selective and orally active JAK3 inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Decernotinib(VX-509)

Decernotinib(VX-509) 25mg  | 99.21%

APEXBIO TECHNOLOGY LLC

Selective and orally active JAK3 inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Decernotinib(VX-509)

mavatrep 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

TRPV1 antagonist Membrane Transporter/Ion Channel|TRPV1

More Information Supplier Page

×

mavatrep

mavatrep 5mg  | 98%

APEXBIO TECHNOLOGY LLC

TRPV1 antagonist Membrane Transporter/Ion Channel|TRPV1

More Information Supplier Page

×

mavatrep

Decernotinib(VX-509) 10mM (in 1mL DMSO)  | 99.21%

APEXBIO TECHNOLOGY LLC

Selective and orally active JAK3 inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Decernotinib(VX-509)